Kinnate Biopharma Inc. (KNTE) Tops Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts KNTE Hot Sheet
Join SI Premium – FREE
Kinnate Biopharma Inc. (NASDAQ: KNTE) reported Q3 EPS of ($0.65), $0.01 better than the analyst estimate of ($0.66).
For earnings history and earnings-related data on Kinnate Biopharma Inc. (KNTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
